EU 4-MBC Sunscreen Ingredient Ban — Effective May 1. Hormone Disruption Concern Enters Daily Sunscreen
The hormone safety of daily-applied sunscreens enters daily life territory. EU bans from May 1, 2026 all cosmetics·sunscreens containing 4-MBC (4-Methylbenzylidene Camphor). Following May 1, 2025 ban on new market introduction with 1-year grace period ending. Thyroid·estrogen disruption concerns + marine accumulation data are decision basis. Even at allowed 4% concentration, post-skin-absorption systemic circulation showed safety margin exceeded. Label name “4-Methylbenzylidene Camphor” or “Enzacamene”. Need to check labels when buying products outside EU.
What Is 4-MBC
4-Methylbenzylidene Camphor (4-MBC):
- Chemical sunscreen ingredient (UV filter)
- INCI name: “4-Methylbenzylidene Camphor”
- Other name: “Enzacamene” (frequently seen on labels)
- Absorbs UV-B range (290~320nm)
- Used worldwide since 1980s
Function:
- UV-B absorption → SPF effect
- Often combined with other UV-B absorbers (octocrylene·octyl methoxycinnamate)
- Relatively good stability
Why Banned — Two Concerns
1. Endocrine Disruption:
- Thyroid disruption: T3·T4 hormone changes in animal studies
- Estrogen disruption: weak estrogen action·anti-androgen action
- Especially risk for reproductive-age women·pregnancy·infants
- Even at 4% concentration, post-skin-absorption systemic circulation safety margin exceeded (EU SCCS evaluation)
2. Marine accumulation:
- Sunscreens flow into oceans·rivers
- Coral bleaching (especially Hawaii·Pacific reefs)
- Marine organism hormone system impact
- 2018 Hawaii banned oxybenzone·octinoxate → 4-MBC follows
EU SCCS (Scientific Committee on Consumer Safety) Evaluation Flow
2024 SCCS opinion:
- 4-MBC safety re-evaluation
- Conclusion: not safe at 4% concentration
- Skin absorption + systemic circulation + hormone impact
May 1, 2025: Ban on new market introduction (added to EU Cosmetic Regulation 1223/2009 Annex II) 2025~2026, 1 year: Existing inventory sale grace May 1, 2026: All 4-MBC-containing products market withdrawal deadline
How to Find on Labels
INCI labeling:
- “4-Methylbenzylidene Camphor”
- “Enzacamene”
- “MBC”
Frequently in products:
- Sunscreens (SPF 15~50)
- Day creams (with SPF)
- Makeup base (with SPF)
- Lip balm (with SPF)
- Some sebum control products
How to check:
- Product back “Ingredients” list
- Search “4-Methylbenzylidene Camphor” or “Enzacamene” word
- If unsure, contact manufacturer customer service
Other Concern Sunscreen Ingredients
Ingredients under EU·US·Asia concern·ban·re-evaluation:
| Ingredient | Concern | Status |
|---|---|---|
| 4-MBC (Enzacamene) | Hormone disruption·marine | EU 2026.5 banned |
| Oxybenzone | Hormone disruption·coral | Hawaii banned·EU partial restriction |
| Octinoxate | Coral·thyroid | Hawaii banned·EU under review |
| Homosalate | Possible hormone disruption | EU SCCS re-evaluating |
| Octocrylene | Time-degraded products (benzophenone) | EU concentration limit |
Safe Alternatives — Mineral vs Chemical Sunscreens
Mineral (Physical):
- Zinc Oxide
- Titanium Dioxide
- No hormone disruption concern
- ↓ marine accumulation concern (some concern with nano forms)
- Cons: white cast·heavy texture
Chemical sunscreen safe options:
- Tinosorb S·M (EU standard, US not approved)
- Mexoryl SX·XL
- Uvinul A Plus
- ↓ hormone disruption concern·↑ stability
Korean user perspective:
- Tinosorb·Mexoryl-containing products active (La Roche-Posay·Avene EU brands)
- US brands frequently contain oxybenzone·homosalate·octinoxate
- Korean own brands gradually shift to mineral·new-gen chemical
Female Impact — Hormone Safety of Daily-Applied Products
Sunscreen use pattern:
- Daily morning (365 days/year)
- Lifetime cumulative exposure
- Wide application: face·neck·arms etc
- Common pregnancy·infant use
What 4-MBC-like hormone disruption concerns mean:
- Lifetime cumulative exposure → even weak effects accumulate
- Pregnancy: placental transfer·infant exposure
- Possible reproductive hormone system impact
- Part of environmental factor matrix like L64 Yale microbiome (estrobolome)
Action Guide — Korean Women
Check current sunscreens:
- Confirm “4-Methylbenzylidene Camphor” or “Enzacamene” on labels
- If found → discontinue use·replace with new product
- Additional evaluation if oxybenzone·homosalate·octinoxate present
New product selection:
- Mineral (zinc oxide·titanium dioxide): safest choice
- New-gen chemical (Tinosorb·Mexoryl): EU brands first
- Confirm Korean MFDS approval·EU approval simultaneously
Especially during pregnancy·lactation:
- Mineral sunscreens recommended
- Avoid 4-MBC·oxybenzone·octinoxate
- OBGYN·dermatologist consultation
Children’s sunscreens:
- Mineral (zinc oxide·titanium dioxide) preferred
- ↓ fragrance·alcohol
- Patch test recommended
Natural Matrix — Multi-Layer UV Protection
Diet:
- Beta-carotene (carrot·spinach·mango)
- Lycopene (tomato·watermelon)
- Vitamin C·E (citrus·nuts)
- Polyphenols (green tea·dark chocolate)
- Omega-3 (fish·flaxseed)
Daily:
- Physical blocking (hat·sunglasses·long clothes·umbrella)
- Avoid strong UV time (10am~4pm)
- UV protection on cloudy days too
Korean Clinical Significance
Korean sunscreen market:
- Rapid annual growth
- Korean MFDS sunscreen ingredient review active
- Korean MFDS may pursue follow-up action after EU 4-MBC ban
Korean MFDS 4-MBC status (May 2026):
- Currently allowed in Korea (4% concentration)
- Korean MFDS re-evaluation possible within months after EU ban
- Consumers should reference EU decision and self-judge·replace
Conclusion
EU 4-MBC ban is the moment when daily-applied sunscreen hormone safety enters daily life territory. Lifetime cumulative exposure + pregnancy·infant impact + marine accumulation matrix. Confirming “4-Methylbenzylidene Camphor” or “Enzacamene” on labels is the first action. Mineral sunscreens·new-gen chemical (Tinosorb·Mexoryl) alternatives. With L64 Yale microbiome + L66 precision medicine penetration + L67 environmental hormone disruption avoidance, a new slot in the female daily precision environmental matrix. Sunscreens become decision variables not just by SPF number but by ingredient safety.